These cumulative observations irrefutably validate the pronounced clinical significance of SLC7A11, affirming its utility as an astute prognostic biomarker specific to ccRCC and conclusively anchoring its interrelation with the course of disease progression [25]. This evidence concerns the gene SLC7A11 and nonpapillary renal cell carcinoma.